"The Hidden Withdrawal Epidemic of Cymbalta (Duloxetine): The Inequities of the Learned Intermediary Doctrine in Cymbalta Litigation and the Necessity of an FDA Re-Evaluation,"
Seton Hall Journal of Legislation and Public Policy: Vol. 47:
2, Article 5.
Available at: https://scholarship.shu.edu/shlj/vol47/iss2/5